REFERENCES
- Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischaemic optic neuropathy. Am J Ophthalmol 2001;132:743–750.
- Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye 2004;18:1188–1206.
- Steigerwalt RD Jr, Belcaro GV, Christopoulos V, Incandela L, Cesarone MR, De Sanctis MT. Ocular and orbital blood flow velocity in patients with peripheral vascular disease and diabetes treated with intravenous prostaglandin E1. J Ocul Pharmacol Ther 2001;17:529–535.
- Steigerwalt RD Jr, Cesarone MR, Belcaro G, Pascarella A, De Angelis M, Bacci S. Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids. Int J Angiol 2008;17:193–196.
- Belcaro G, Laurora G, Nicolaides AN, Agus G, Cesarone MR, DeSanctis MT, Incandela L, Ricci A, Cazaubon M, Ippolito E, Barsotti A, Vasdekis S, Ledda A, Iacobitti P, Christopoulos D, Errichi BM, Helmis H, Cornelli U, Ramaswami G, Bucci M, Ferrari PG, Corsi M, Pomante P, Mezzanotte L, Geroulakos G. Treatment of severe intermittent claudication with PGE1. A short-term versus a long-term infusion plan. A 20-week, European, randomized trial. Analysis of efficacy and costs. Angiology 1998;49:885–895.
- Belcaro G, Nicolaides AN, Agus G, Cesarone MR, Geroulakos G, Pellegrini L, De Sanctis MT, Incandela L, Ricci A, Mondani P, De Angelis R, Ippolito E, Barsotti A, Vasdekis S, Ledda A, Christopoulos D, Errichi BM, Helmis H, Cornelli U, Ramaswami G, Dugall M, Bucci M, Martines G, Ferrari PG, Corsi M, Di Francescantonio D. PGE1 treatment of severe intermittent claudication (short-term versus long-term), associated with exercise efficacy and costs in a 20-week, randomized trial. Angiology 2000;51(Suppl):S15–S26.
- Nagai A, Kusumi N, Tsuboi H, Ishii K, Saika T, Nasu Y, Kumon H. Intracavernous injection of prostaglandin E 1 is effective in patients with erectile dysfunction not responding to phosphodiseterase 5 inhibitors. Acta Med Okayama 2005;59:279–280.
- Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Christopoulos D, Agus G, Bavera P, Mondani P, Ippolito E, Flenda F. [Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs]. Minerva Cardioangiol 2002;50:683–690 [Italian].
- Parfitt K. Prostaglandins. In: Parfitt K, ed. Martingale. The Complete Drug Reference. London, UK: Pharmaceutical Press, 1999:1411–1413.
- Schror K, Hohlfeld T. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease. Vasa 2004;33:119–124.
- Steigerwalt RD Jr, Pescosolido N, Corsi M, Cesarone MR, Belcaro GV. Acute branch retinal arterial embolism successfully treated with intravenous prostaglandin E1. Case Reports. Angiology 2003;54:491–493.
- Steigerwalt RD Jr, Cesarone MR, Belcaro G, Pascarella A, Rapagnetta L, De Angelis M, Nebbioso M. Ocular ischemia in high myopia treated with intravenous prostaglandin E1. Retinal Cases Brief Rep 2009;3:379–382.
- Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008;246:1029–1046.
- Collard CD, Gelman S. Pathophysiology, clinical manifestations and prevention of ischemia-reperfusion injury. Anesthesiology 2001;94:1133–1138.
- Kurokawa T, Takagi H. Mechanisms and prevention of ischemia-reperfusion injury. Transplant Proc 1999;31:1775–1776.